| Oryzon

Skip to main content

English
Español

Company
- Overview
- Strategy
- Team
Epigenetics
- Epigenetics
- LSD1
Programs
Patients
- Clinical Trials
Investors
News & Events
- Press releases
- Events
Contact

Search

Breadcrumb

Home

15-17 November 2022

Jefferies London Healthcare Conference 2022

London

United Kingdom

14 November 2022

Inv€$tival Showcase LSX Leaders 2022

London

United Kingdom

10-11 November 2022

11th Drug Discovery Strategic Summit

Amsterdam

Netherlands

4 November 2022

Kabuki Syndrome Foundation Annual Conference

4 November 2022

ORYZON to give updates on corporate progress in November

2 November 2022

ORYZON reports results and corporate update for quarter ended September 30, 2022

26-28 October 2022

34th EORTC-NCI-AACR Symposium

Barcelona

Spain

24-26 October 2022

BIO-Europe 2022

Leipzig

Germany

13-14 October 2022

HealthTech Innovation Days

Paris

France

11-12 October 2022

Brain Innovation Days

Brussels

Belgium

Pagination

First page «
Previous page ‹
Page 17
Page 18
Page 19
Page 20
Current page 21
Page 22
Page 23
Page 24
Page 25
Next page ›
Last page »

Subscribe to

Company

Overview
Strategy
Team

Epigenetics

Epigenetics
LSD1

Programs

Pipeline
Iadademstat
Vafidemstat
Collaborations
Publications

Patients

Clinical Trials

Investors

Share Information
Financial Information
CNMV Filings
Analyst Coverage
Corporate Governance
Corporate Social Responsibility

News & Events

Press releases
Events

Contact

Contact
Email Alerts
Join us

© Oryzon Genomics, S.A. - All Rights Reserved

Legal
Privacy Policy
Cookie Policy
Ethics Channel